Clinical trial

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

NCT07257068

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-09-14

PhaseNA

Study timeline

Study start (estimated)2026-09-14Date precision: day

Registry last updated2026-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Checkpoint Inhibitorunresolved

Pilot Studyunresolved

Diabetes Melletusunresolved

Interventions

InfliximabOTHER

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07257068 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.